SK Biopharmaceuticals Co., Ltd. (KRX:326030)
91,500
-900 (-0.97%)
Last updated: Jun 26, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.15 trillion as of June 27, 2025. Its market cap has increased by 10.53% in one year.
Market Cap
7.15T
Enterprise Value
7.03T
Revenue
578.00B
Ranking
n/a
PE Ratio
28.46
Stock Price
91,500.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.15T, a decrease of -28.11%. That is a compound annual growth rate of -6.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 7,150.00B | -17.82% |
Dec 30, 2024 | 8,700.60B | 10.66% |
Dec 28, 2023 | 7,862.65B | 39.25% |
Dec 29, 2022 | 5,646.39B | -25.82% |
Dec 30, 2021 | 7,612.05B | -42.49% |
Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 71.46T |
Celltrion | 35.49T |
ALTEOGEN | 20.84T |
Yuhan | 7,640.71B |
HLB Co., Ltd. | 6,499.30B |
PharmaResearch | 4,992.23B |
Peptron | 4,741.01B |
SK bioscience | 3,973.32B |